Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 34.70p 34.00p 35.40p 35.40p 34.30p 34.70p 239,292 15:01:38
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -10.4 -13.5 - 40.07

Avacta Share Discussion Threads

Showing 4401 to 4423 of 4425 messages
Chat Pages: 177  176  175  174  173  172  171  170  169  168  167  166  Older
DateSubjectAuthorDiscuss
17/1/2019
09:13
SensibleWith upcoming news flow these levels are ridiculous cheap.New buyers will pick up stock, I suspect with the news flow in this Brexit bulletproof stock and growing M&A activity in the sector in the US etc. Another deal etc will re rate the stock substantially.Good choice 37 again this afternoonMM does not have the stock for a proper buyer
hampton58
17/1/2019
09:09
The finnCap target is 120p, the CEO sees the shares as "woefully undervalued" and the market capitalisation of comparitors is multiples of the current share price. Any investement around the current level is likely to reap significant rewards over time. It's just a case of being patient and waiting for the newsflow to come in.
cf456
17/1/2019
09:08
bought another 10k. Will be happy to pick up more if it drifts...
bumpa33
17/1/2019
08:50
30 would be an effective re test of the breakout, not impossible if we get a few more bored sellers, though I think the world and it’s wife would be jumping in at that level/opportunity.
bumpa33
17/1/2019
08:34
Added 20,000 this morning.
the drewster
16/1/2019
14:55
I'm hoping of a fall to 30p so I can top up...
blackbear
16/1/2019
14:27
Looking forward to further deals landing. I'd think that there will be a number of them in 2019. -- "And Alastair, with this deal in place here do you reckon this will help accelerate other agreements? Yes, I think that's very likely. The validation of the Affimer technology through these types of commercial partnerships should certainly be a catalyst for others, yes." hTTp://goo.gl/Bd43NH (from 3:05)
cf456
16/1/2019
00:46
Remember LG mentioned Avacta during their presentation at JP Healthcare conference
hampton58
15/1/2019
22:48
Drewster Please ask for detail on the LG deal at the AGM. Many thanks.
lantanatony
15/1/2019
18:18
AGM next Monday ...
the drewster
15/1/2019
14:04
Yes, that makes sense. The last RNS provided a liquidity event which allowed the likes of Aviva to reduce their position and the other instis to buy. The next positive RNS and it'll be a lot more difficult to buy a decent position since the recent insitutional purchases have tied up the loose stock. And of course it's not just a single positive RNS expected. There should be several of them over the coming months. I can see the price being chased a lot higher as the news starts to flow in earnest.
cf456
15/1/2019
13:59
indeed - last time was a one-off opportunity due to the ii's shifting around plus i'm sure some placing stock still about. It feels now like everyone has their position so I suspect the supply of stock just won't be there next time.
bumpa33
15/1/2019
13:56
Agreed. There's a reason the instis have been loading up heavily over the past few weeks and it's not for a quick 10% to 20%. JO Hambro of interest in particular. They more than doubled their stake to nearly 11% of the company.
cf456
15/1/2019
13:50
if we get good news here again, this time it'll be almost impossible to buy with the minimal free float out there. These current sells are 'boredom' trades i'm sure...
bumpa33
15/1/2019
13:47
Buy when others are fearful, sell when others are greedy a good general maxim. Most don't though and end up having to pay a lot higher when they chase after good news gaps the price up. Better to buy before the good news. And there should be plenty of that this year.
cf456
15/1/2019
13:41
picked a few up here at 34.8, but hardly anything on offer, despite the dip.
bumpa33
15/1/2019
13:32
Dip presenting itself for a pullback entry opportunity.
cf456
15/1/2019
08:00
Latest presentation from October full of useful info and worth a read: "Considerable uplift opportunity Significant milestones should be achieved in the near future that would support considerable valuation uplift and bring Avacta inline with comparators." hTTps://tinyurl.com/ybl6sybj
cf456
14/1/2019
15:12
Another speaker at Avacta's Science Day is Joseph Tabernero,not only is he head of the Medical Oncology department at Vall d'Hebron Barcelona Hospital, he is also ESMO president of the European Society for Medical Oncology as well as member of the American Association for Cancer Research.He also serves on the Editorial board of various top tier Oncology Journals.Along with the Professor Bachovchin from Tufts and the newly appointed Chief Medical Officer dr.Saro from Roche and off course the CEO Alastair Smith of Avacta just back from JP Morgan's healthcare conference presenting ,it promises to be a very interesting event for the Fund manager community.
hampton58
14/1/2019
13:12
Maybe a couple of delayed 50k buys will pop up later. The price has certainly been firm whilst there have been a few small sells. Instis mopping up whilst small PIs sell. I know which side I'd rather be on. Profit taking to be expected I suppose with so many traders in the market these days. But they're missing out on a very much bigger opportunity here imo. The company is at an inflection point. It's hugely undervalued compared to comparitors and with multiple catalysts in the weeks and months ahead, I expect the share price to move very much higher over time.
cf456
14/1/2019
12:50
Yep definitely something happening - can’t get a quote for £500 at the moment but can sell everything well above the advertised bid. A TR1 from a new buyer would be tasty.
74tom
14/1/2019
12:15
Possible that background buying has been going on and delayed trades still to print especially given that you can buy next to nothing at the offer.
cf456
14/1/2019
10:29
All buys so far today with one bed and ISA just before 9 that was made to look like back to back sells... real bid is 37p, so we’ll see a quick rise with any more buying :)
74tom
Chat Pages: 177  176  175  174  173  172  171  170  169  168  167  166  Older
Your Recent History
LSE
AVCT
Avacta
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190117 20:05:55